Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy

Muscle and Nerve

Volumn 24, Issue 2, 2001, Pages 192-202

  Skrabek, R Q ^a   Anderson, J E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

bFGF; Cardiomyopathy; Deflazacort; H NMR spectroscopy; Laminin; mdx mouse; Muscular dystrophy; Taurine

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DEFLAZACORT; GLYCINE; MYOSIN HEAVY CHAIN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART PROTECTION; INFLAMMATORY CELL; LEG MUSCLE; MESSENGER RNA SYNTHESIS; METABOLIC REGULATION; MOUSE; MUSCLE HYPERTROPHY; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY OF LIFE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARDIOMYOPATHIES; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LAMININ; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED MDX; MYOCARDIUM; MYOSIN HEAVY CHAINS; PREGNENEDIONES; TAURINE;

EID: 0035143576     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200102)24:2<192::AID-MUS40>3.0.CO;2-S     Document Type: Article

References (57)

1. Taurine in normal and diseased human skeletal muscle
2. Dystrophy and myogenesis in the mdx diaphragm muscle
3. The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: Greater dystrophy in cardiac and soleus muscle
4. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse
5. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy
6. Hormonal and neurogenic control of Na-K-ATPase and myosin isoforms in neonatal rat cardiac myocytes
7. The heart in Duchenne muscular dystrophy: A non-invasive longitudinal study
8. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
9. Systolic time intervals in Duchenne muscular dystrophy: Evaluation of left ventricular performance
10. Taurine: Its biological role and clinical implications
11. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Effect of taurine on excitation contraction coupling of extensor digitorum longus muscle of the dystrophic mdx mouse
14. Electrical properties of diaphragm and EDL muscles during the life of dystrophic mice
15. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo
16. Progressive hypertrophy and heart failure in beta 1-adrenergic receptor transgenic mice
17. Change in synthesis rates of α- and β-myosin heavy chains in rabbit heart after treatment with thyroid hormone
18. Regulation of myosin synthesis by thyroid hormone: Relative change in the α- and β-myosin heavy chain mRNA levels in rabbit heart
19. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors
20. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
21. Basic fibroblast growth factor in cardiac myocytes: Expression and effects
22. Corticosteroid therapy in Duchenne muscular dystrophy
23. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats
24. Dexamethasone effects on inducible nitric oxide synthase and nitrite/nitrate production in myocardial infarction
25. Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice
26. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus deflazacort
27. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions
28. Deflazacort: A review of its pharmacological properties and therapeutic efficacy
29. Magnetic resonance imaging of regenerating and dystrophic mouse muscle
30. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles
31. A nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: Correlation with repair
32. Application of 1H NMR spectroscopy for qualitative measurement of muscle carnitine levels
33. Hypothalamic-pituitary thyroid abnormalities in children after renal transplantation
34. 1-H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus
35. High resolution 1H-NMR spectroscopy studies of extracts of human cerebral neoplasms
36. Improved cardiac gating and ventilation timing in animal experiments
37. Dynamic 13C NMR analysis of pyruvate and lactate oxidation in the in vivo canine myocardium: Evidence of reduced utilization with increased work
38. Role of cardiac renin-angiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction
39. Deflazacort vs. prednisone in Duchenne muscular dystrophy: Trends of an ongoing study
40. 13C NMR analysis of oxidative metabolism in the in vivo canine myocardium
41. In vivo magnetic resonance methods in pharmaceutical research: Current status and perspectives
42. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: A two-dimensional echocardiographic study
43. Review: Myocardial physiological effects of taurine and their significance
44. Infrared spectroscopy of dystrophic mdx mouse muscle tissue distinguishes among treatment groups
45. Gated magnetic resonance imaging of normal and hypertrophied murine hearts
46. Immunolocalization of rat cardiac β-MHC protein expression in systemic hypertension and caloric restriction
47. High-resolution proton NMR studies of lymphocyte extracts
48. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle
49. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy
50. Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro
51. Dissociation of left ventricular hypertrophy, β-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis
52. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency